KAYLA YATES: Open Payments
NPI 1215547237 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 107 payments from 17 companies in 2025. Trend: 2023 $588 · 2024 $931 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $308 |
| Novo Nordisk Inc | 16 | $298 |
| AstraZeneca Pharmaceuticals LP | 13 | $200 |
| Amgen Inc. | 22 | $198 |
| GlaxoSmithKline, LLC. | 7 | $150 |
| Exact Sciences Corporation | 6 | $126 |
| Esperion Therapeutics, Inc. | 5 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $55 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, UBRELVY, FARXIGA, OTEZLA, Wegovy, QULIPTA, NEXLETOL.
Industry payments across TN — which companies pay providers there.
